Allergy Immunotherapy Market Key Is Expected to Reach 2210 Million US$ by 2025

This report studies the Allergy Immunotherapies (Allergy Immunotherapy) market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

The classification of Allergy Immunotherapy includes Subcutaneous Immunotherapy and Sublingual Immunotherapy. The proportion of Subcutaneous Immunotherapy in 2017 is about 55.1%, and the proportion of Sublingual Immunotherapy in 2016 is about 44.9%. Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.3 % in 2017.

Europe is the largest consumption place, with a consumption market share nearly 68.5% in 2017, Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction. Following Europe, North America is the second largest consumption place with the consumption market share of 19.2% in 2017. Allergy Immunotherapy market in Asia Pacific region is expected to exhibit the highest growth rate due to high incidence of allergy people in the developing Asian countries like China & India.

Market competition is intense. ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, etc. are the leaders of the industry with the market share is about 76.6% in 2017. In 2017, the global Allergy Immunotherapies (Allergy Immunotherapy) market size was 1070 million US$ and it is expected to reach 2210 million US$ by the end of 2025, with a CAGR of 9.5% between 2018 and 2025.

This report focuses on the global top players, covered

ALK-Abello

Stallergenes Greer

Merck

Allergy Therapeutics

HAL

WOLW Pharma

Holister Stier

Leti

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/606421/global-allergy-immunotherapies-allergy-immunotherapy-market.

Market size split by Region

•North America
•Asia-Pacific
•Europe
•Central & South America
•Middle East & Africa

Benefits of Purchasing QY Research Report

• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
•Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
• Inimitable Expertise: Analysts will provide deep insights about the reports
• Assured Quality: We focus on the quality and accuracy of the report

Buy Full market Report Now, Report delivery time within 24 hours @
https://www.qyresearch.com/settlement/pre/e68efbbac7e961fef988bc8c560d51ec,0,1

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

This release was published on openPR.